China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
China Resources Boya Bio pharmaceutical Group Co Ltd
Operating Income
China Resources Boya Bio pharmaceutical Group Co Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
|
Operating Income
¥549.8m
|
CAGR 3-Years
18%
|
CAGR 5-Years
0%
|
CAGR 10-Years
22%
|
|
Beigene Ltd
HKEX:6160
|
Operating Income
-¥12B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Operating Income
-¥1.1B
|
CAGR 3-Years
-36%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Operating Income
¥1.4B
|
CAGR 3-Years
22%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Operating Income
¥9.9B
|
CAGR 3-Years
38%
|
CAGR 5-Years
46%
|
CAGR 10-Years
47%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Operating Income
¥1.4B
|
CAGR 3-Years
59%
|
CAGR 5-Years
72%
|
CAGR 10-Years
N/A
|
See Also
What is China Resources Boya Bio pharmaceutical Group Co Ltd's Operating Income?
Operating Income
549.8m
CNY
Based on the financial report for Dec 31, 2023, China Resources Boya Bio pharmaceutical Group Co Ltd's Operating Income amounts to 549.8m CNY.
What is China Resources Boya Bio pharmaceutical Group Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
22%
Over the last year, the Operating Income growth was 7%. The average annual Operating Income growth rates for China Resources Boya Bio pharmaceutical Group Co Ltd have been 18% over the past three years , and 22% over the past ten years .